Search Within

Ronald A Ghossein

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (76)
  2. Meeting Abstract (27)
  3. Editorial (1)
  4. Guidelines (1)
Groups
  1. Department of Pathology and Laboratory Medicine (105)
  2. GSK Faculty (105)
  3. Human Oncology and Pathogenesis Program (105)
  4. Department of Medicine (90)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (84)
  6. Division of Subspecialty Medicine (84)

More Groups

People
  1. James Fagin (84)
  2. Robert Tuttle (36)
  3. Jeffrey Knauf (34)
  4. Ian Ganly (26)
  5. Bin Xu (25)
  6. Alan Ho (21)

More People

Years
  1. 2025 (3)
  2. 2024 (6)
  3. 2023 (5)
  4. 2022 (14)
  5. 2021 (3)
  6. 2020 (15)

More Years

Publications
  1. Modern Pathology (12)
  2. Nature Communications (10)
  3. Thyroid (10)
  4. Cancer Research (8)
  5. Journal of Clinical Endocrinology and Metabolism (8)
  6. Laboratory Investigation (7)

More Publications

Publishers
  1. Nature Publishing Group (20)
  2. American Association for Cancer Research (17)
  3. Nature Research (12)
  4. Mary Ann Liebert, Inc (10)
  5. Oxford University Press (9)
  6. Springer (7)

More Publishers

Results (105)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective comparison of F-18-TFB and I-124 PET/CT in metastatic thyroid cancer
    Meeting Abstract

    Backhaus, P.; Pentlow, K.; Ho, A. L.; Mauguen, A.; Fagin, J. A.; Pillarsetty, N. V. K.; Lyashchenko, S. K.; Burnazi, E.; Ghossein, R. A.; Chhabra, S.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): A regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients
    Journal Article

    Mauguen, A.; Grewal, R. K.; Augensen, F.; Abusamra, M.; Mahajan, S.; Jayaprakasam, V. S.; Osborne, J.; Haque, S.; Wong, B. Z. Y.; Ghossein, R. A.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Loss of CDKN2A/B is a molecular marker of high-grade histology and is associated with aggressive behavior in acinic cell carcinoma
    Journal Article

    Dogan, S.; Xu, B.; Rana, S.; Chen, H.; Ghossein, R. A.; Berger, M. F.; Ho, A. L.; Katabi, N.
    Modern Pathology (2023)

    Fulltext@MSK | Save
  • Genomic and transcriptomic characteristics of metastatic thyroid cancers with exceptional responses to radioactive iodine therapy
    Journal Article

    Boucai, L.; Saqcena, M.; Kuo, F.; Grewal, R. K.; Socci, N.; Knauf, J. A.; Krishnamoorthy, G. P.; Ryder, M.; Ho, A. L.; Ghossein, R. A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • TERT mutant promoter mouse model induces cancer progression in Braf(V600E)-driven thyroid tumors: A novel tool to understand the biology of telomerase-reactivated cancers
    Meeting Abstract

    Landa, I.; Hao, J. Z.; Xu, B.; Giacalone, J.; Herbert, Z.; Blasco, M. A.; Knauf, J. A.; Ghossein, R.; Fagin, J. A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitors
    Journal Article

    Garcia-Rendueles, M. E. R.; Krishnamoorthy, G.; Saqcena, M.; AcunĖƒa-Ruiz, A.; Revilla, G.; de Stanchina, E.; Knauf, J. A.; Lester, R.; Xu, B.; Ghossein, R. A.; more...
    Molecular Cancer (2022)

    Fulltext@MSK | Save
  • Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)
    Meeting Abstract

    Burman, B.; Tuttle, R. M.; Grewal, R. K.; Sherman, E. J.; Baxi, S. S.; Boucai, L.; Sabra, M.; Fish, S.; Pentlow, K. S.; Haque, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Active surveillance of papillary thyroid cancer: Frequency and time course of the six most common tumor volume kinetic patterns
    Journal Article

    Tuttle, R. M.; Fagin, J.; Minkowitz, G.; Wong, R.; Roman, B.; Patel, S.; Untch, B.; Ganly, I.; Shaha, A.; Shah, J.; more...
    Thyroid (2022)

    Fulltext@MSK | Save
  • A pilot study of durvalumab (MEDI4736) with tremelimumab in combination with image-guided stereotactic body radiotherapy in the treatment of metastatic anaplastic thyroid cancer
    Journal Article

    Lee, N. Y.; Riaz, N.; Wu, V.; Brinkman, T.; Tsai, C. J.; Zhi, W.; Fetten, J.; Ho, A.; Wong, R. J.; Ghossein, R.; more...
    Thyroid (2022)

    Fulltext@MSK | Save
  • Prolonged survival of anaplastic thyroid carcinoma is associated with resectability, low tumor-infiltrating neutrophils/myeloid-derived suppressor cells, and low peripheral neutrophil-to-lymphocyte ratio
    Journal Article

    Xu, B.; Zhang, L.; Setoodeh, R.; Mohanty, A. S.; Landa, I.; Balzer, B.; Tiedje, V.; Ganly, I.; Dogan, S.; Fagin, J. A.; more...
    Endocrine (2022)

    Fulltext@MSK | Save